In allergic diseases; we all know that allergens may have regional variations. That's why; the allergen profiles of the regions must be determined and the dermal Prick tests must be prepared accordingly. Mostly grass and cereal mixtures and mites are responsible from the allergic rhinitis cases due to our observations in our clinic. The other important allergens that are linked to the flora and climate of the region are olive and the cockroaches. High asthma prevalence in people living in shanties and in housewives may be due to exposure to house dust mites. Background: Prevalence of allergic disease has increased in recent years all over the world. Asthma and rhinitis are the most prevalent in Portugal and, having them such a multi-factorial basis, atopy is the most important risk factor for its development. The authors aim to evaluate mono/polisensitization as risk factors for severity of allergic disease, if there is an impact in allergic disease manifestations number, the different treatment response, and if there is a relationship between VEMs, comorbilities and sensitization. Methods: In a population of patients followed in asthma/allergology appointment were selected those with asthma and allergic rhinitis confirmed by cutaneous test and/or specific IgE. Clinical processes were reviewed and analyzed data related to the age of beginning, manifestations, atopic profile, severity, treatment, comorbilities and functional limitation. A descriptive analysis of the sample was made and used linear regression for variable correlations. Results: 176 patients 30% men and 70% women, mean age 33,7 and mean age of early symptoms 12,7 Of these, 94% had asthma and 85% rhinitis. They were 53% monosensitized, 47% polisensisitized and 43% had comorbilities. 66,5% of patients has done specific immunotherapy (SIT). On linear regression analysis it was found that different sensitization has not been determinative for disease manifestations number neither of treatment response. It was observed that severity of asthma and rhinitis correlate with each other (P , 0,001), but no significant differences were verified in severity level between patients mono vs polisensitized. SIT demonstrate a positive and statistically significant correlation with treatment reduction (P , 0,001) and reduction on asthma and rhinitis severity (P ¼ 0,015 and P , 0,001). SIT patients also demonstrate a decrease in asthma severity associated to the number of allergen sensitizations. It was found a positive correlation between the presence and number of comorbilities and asthma and rhinitis severity (P ¼ 0,001/P , 0,001 and P ¼ 0,007/P ¼ 0,001), instead of individually, only nasal polyposis prove to be associated with statistical significance. Comorbilities were also related with a lower FEV1 (P ¼ 0,02). Conclusions: This study supports literature data, which says there is only one allergic disease and that severity of disease extends to its various manifestations. We confirmed that in atopic patients, SIT has benefit in the reduction on allergic disease severity and a better disease control with minor therapeutic use. Background: The diagnosis of allergic rhinitis (AR) is based on clinical manifestations and supported by a positive result for skin prick test (SPT) or serum specific immunoglobulin E (sIgE) antibodies to aeroallergens. Our objective was to investigate the frequency of patients with clinical manifestations of AR without evidence of specific IgE sensitization. Methods: We evaluated patients with clinical manifestations suggestive of AR, other causes of rhinitis excluded, aged .5 years and who had total serum IgE and SPT or sIgE to aeroallergens measured. Skin tests were performed with extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae, Blomia tropicalis and Aspergillus fumigatus (FDA Allergenic) and total serum IgE and sIgE, for the same allergens, by ImmunoCAP (Phadia). Patients were subdivided into groups according to the results profile, and comparatively analyzed for association with asthma, severity of rhinitis and age. Results: We evaluated 116 patients (64% female) aged between 5 and 79 years, including 34 children (29%) and 63 (54%) with bronchial asthma. The observed profiles and frequencies were: high IgE levels and positivity in the SPT or sIgE -55%; normal IgE levels and SPT or sIgE positivity -9%; high IgE levels and SPT and sIgE negativity -3 %; normal IgE levels and negativity in the SPT and sIgE -23%. Among patients with normal levels of total serum IgE and no evidence of specific IgE sensitization, 14% had asthma, while in the remainder the prevalence of asthma was 34% (P ¼ 0.0009). There was no statistical significance in the influence of the rhinitis severity and age in the absence of markers of atopy and allergen sensitization. Conclusions: We observed a significant number of patients with clinical manifestations of AR, without evidence of systemic atopy and specific IgE sensitization, indicating the importance of careful research of local allergic rhinitis, as well as other causes of chronic rhinitis. Local allergic rhinitis appears to be less frequent in patients with rhinitis and asthma. The observation of 13% of patients with elevated levels of total IgE without specific sensitization implies the possibility of sensitization to aeroallergens which were not investigated, such as occupational allergens.
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